甲强龙球旁注射治疗重症HSK的临床疗效分析
The Clinical Efficacy of Methylprednisolone Sodium Succinate for Periocular Injection in the Treatment of Severe Herpes Simplex Keratitis
摘要: 目的:探究甲强龙治疗重症单纯疱疹病毒角膜炎(herpessimplex keratitis, HSK)的临床疗效。方法:一项回顾性病例分析研究。收集自2018年1月至2019年1月因重症HSK在我院眼科住院治疗的47例患者(47眼)的临床资料进行分析研究。按治疗方式随机分成两组:观察组(25眼)和对照组(22眼)。对照组:常规治疗,观察组:常规治疗基础上,联合甲强龙球旁注射。观察指标:治疗3周后的最佳矫正视力(The best corrected visual acuity, BCVA)和有效率;随访1年时复发率和BCVA。结果:治疗3周后,观察组BCVA明显优于对照组(P < 0.05),观察组(92.00%)有效率高于对照组(68.18%) (P < 0.05)。治疗1年后,观察组BCVA明显优于对照组(P < 0.05),观察组复发率(16.00%)与对照组(22.73%)无明显统计学差异(P > 0.05)。结论:球旁注射甲强龙可有效缩短重症HSK病程,对患者的视力改善效果显著,同时可明显提高治疗的有效率,值得临床推广应用。
Abstract: Purpose: To investigate the clinical efficacy of Methylprednisolone sodium succinate for periocular injection in the treatment of severe herpes simplex keratitis (HSK). Methods: A retrospective case analysis study. A cohort of 47 patients (47 eyes) with severe HSK recruited between January 2018 and January 2019 was randomly divided into two groups according to the treatment they received: observation group (25 eyes) and control group (22 eyes). The control group: conventional treatment; observation group: conventional treatment combined with periocular injection of methylprednisolone sodium succinate. The best corrected visual acuity (BCVA) and effective rate was recorded after 3 weeks of treatment. The recurrence rate and BCVA were recorded followed up at 1 year. Results: After 3 weeks of treatment, BCVA in the observation group was significantly better than that in the control group (P < 0.05). The effective rate of the observation group (92.00%) was significantly better than the control group (68.18%) (P < 0.05). After 1 year of treatment, BCVA in the observation group was significantly better than that in the control group (P < 0.05). There was no significant difference in the recurrence rate between the observation group (16.00%) and the control group (22.73%) (P > 0.05). Conclusion: Periocular injection of methylprednisolone sodium succinate can effectively shorten the course of HSK, significantly improve the visual acuity of patients, significantly increase the effective rate of treatment, and be worthy of clinical application.
文章引用:孙珊珊, 孙倬. 甲强龙球旁注射治疗重症HSK的临床疗效分析[J]. 临床医学进展, 2021, 11(9): 3930-3935. https://doi.org/10.12677/ACM.2021.119575

参考文献

[1] Danileviciene, V., Zemaitiene, R., Gintauskiene, V.M., et al. (2019) Corneal Sub-Basal Nerve Changes in Patients with Herpetic Keratitis during Acute Phase and after 6 Months. Medicina (Kaunas, Lithuania), 55, 214. [Google Scholar] [CrossRef] [PubMed]
[2] Roizman, B. and Whitley, R.J. (2013) An Inquiry into the Molecular Basis of HSV Latency and Reactivation. Annual Review of Microbiology, 67, 355-374. [Google Scholar] [CrossRef] [PubMed]
[3] Koyuncu, O.O., MacGibeny, M.A. and Enquist, L.W. (2018) Latent versus Productive Infection: The Alpha Herpesvirus Switch. Future virology, 13, 431-443. [Google Scholar] [CrossRef] [PubMed]
[4] Koyuncu, O.O., Hogue, I.B. and Enquist, L.W. (2013) Virus Infections in the Nervous System. Cell Host & Microbe, 13, 379-393. [Google Scholar] [CrossRef] [PubMed]
[5] Semeraro, F., Forbice, E., Romano, V., et al. (2014) Neurotrophic Keratitis. Ophthalmologica Journal International d’ophtalmologie International Journal of Ophthalmology Zeitschrift fur Augenheilkunde, 231, 191-197. [Google Scholar] [CrossRef] [PubMed]
[6] Farooq, A.V. and Shukla, D. (2012) Herpes Simplex Epithelial and Stromal Keratitis: An Epidemiologic Update. Survey of Ophthalmology, 57, 448-462. [Google Scholar] [CrossRef] [PubMed]
[7] Rolinski, J. and Hus, I. (2014) Immunological Aspects of Acute and Recurrent Herpes Simplex Keratitis. Journal of Immunology Research, 2014, 1-9. [Google Scholar] [CrossRef] [PubMed]
[8] Naumovska, M., Sheikh, R., Bengtsson, B., et al. (2018) Visual Outcome Is Similar in Optic Neuritis Patients Treated with Oral and i.v. High-Dose Methylprednisolone: A Retrospective Study on 56 Patients. BMC Neurology, 18, 160. [Google Scholar] [CrossRef] [PubMed]
[9] Morrow, S.A., Fraser, J.A., Day, C., et al. (2018) Effect of Treating Acute Optic Neuritis with Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial. JAMA Neurology, 75, 690-696. [Google Scholar] [CrossRef] [PubMed]
[10] 刘燕霞, 赵敏. 加替沙星胶联羊膜药膜治疗细菌感染性角膜炎模型兔的疗效[J]. 中国老年学杂志, 2017, 37(15): 3650-3653.
[11] 张帅. 糖皮质激素治疗基质型单疱病毒性角膜炎的临床效果观察[J]. 临床合理用药杂志, 2019, 12(19): 111-112.
[12] 黄天宏. 阿昔洛韦滴眼液联合糖皮质激素治疗重度病毒性角膜炎的疗效及安全性分析[J]. 吉林医学, 2019, 40(7): 1529-1530.
[13] 梁玲燕. 阿昔洛韦滴眼液联合糖皮质激素治疗重度病毒性角膜炎的疗效及安全性分析[J]. 全科口腔医学电子杂志, 2019, 6(27): 179.